{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T01:02:28Z","timestamp":1786410148795,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Sickle cell anemia (SCA) presents a complex pathophysiology which can be affected by a number of modifying factors, including genetic and biochemical ones. In Brazil, there have been no studies verifying \u03b2<jats:sup>S<\/jats:sup>-haplotypes effect on oxidative stress parameters. This study evaluated \u03b2<jats:sup>S<\/jats:sup>-haplotypes and Hb F levels effects on oxidative stress markers and their relationship with hydroxyurea (HU) treatment in SCA patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The studied group was composed by 28 SCA patients. Thirteen of these patients were treated with HU and 15 of them were not. We used molecular methodology (PCR-RFLP) for hemoglobin S genotype confirmation and haplotypes identification. Biochemical parameters were measured using spectrophotometric methods (Thiobarbituric-acid-reactive substances and Trolox equivalent antioxidant capacity levels, catalase and GST activities) and plasma glutathione levels by High-performance liquid chromatography coupled to electrochemical detection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found the highest frequency of Bantu haplotype (48.2%) which was followed by Benin (32.1%). We observed also the presence of Cameroon haplotype, rare in Brazilian population and 19.7% of atypical haplotypes. The protective Hb F effect was confirmed in SCA patients because these patients showed an increase in Hb F levels that resulted in a 41.3% decrease on the lipid peroxidation levels (r\u2009=\u22120.74, p=0.01). Other biochemical parameters have not shown differential expression according to patient\u2019s haplotypes. Bantu haplotype presence was related to the highest lipid peroxidation levels in patients (p\u2009&lt;\u20090,01), but it also conferred a differential response to HU treatment, raising Hb F levels in 52.6% (p\u2009=\u20090.03) when compared with the group with the same molecular profile without HU usage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>SCA patients with Bantu haplotype showed the worst oxidative status. However these patients also demonstrated a better response to the treatment with HU. Such treatment seems to have presented a \u201chaplotype-dependent\u201d pharmacological effect.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2350-14-108","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T11:04:45Z","timestamp":1381403085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia"],"prefix":"10.1186","volume":"14","author":[{"given":"Danilo Grunig Humberto","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edis","family":"Belini Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele Cristine de Souza","family":"Carrocini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidiane de Souza","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oct\u00e1vio","family":"Ricci J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse Lopes de Castro","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Regina","family":"Bonini-Domingos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Alves","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,9]]},"reference":[{"key":"1140_CR1","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","volume":"115","author":"RE Ware","year":"2010","unstructured":"Ware RE: How I use hydroxyurea to treat young patients with sickle cell anemia. Blood. 2010, 115: 5300-5311. 10.1182\/blood-2009-04-146852.","journal-title":"Blood"},{"key":"1140_CR2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.84.3.500","volume":"84","author":"SL Leikin","year":"1989","unstructured":"Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W: Mortality in children and adolescents with sickle cell disease: cooperative study of sickle cell disease. Pediatrics. 1989, 84: 500-508.","journal-title":"Pediatrics"},{"key":"1140_CR3","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1056\/NEJMc066547","volume":"356","author":"GR Serjeant","year":"2007","unstructured":"Serjeant GR, Higgs DR, Hambleton IR: Elderly survivors with homozygous sickle cell disease. N Engl J Med. 2007, 356: 642-643. 10.1056\/NEJMc066547.","journal-title":"N Engl J Med"},{"key":"1140_CR4","first-page":"239","volume":"39","author":"AE Kulozik","year":"1986","unstructured":"Kulozik AE, Wainscoat JS, Serjeant GR, Kar BC, Al-Awamy B, Essan GJ, et al: Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. Am J Hum Genet. 1986, 39: 239-244.","journal-title":"Am J Hum Genet"},{"key":"1140_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/01.moh.0000219656.50291.73","volume":"13","author":"MH Steinberg","year":"2006","unstructured":"Steinberg MH, Adewoye AH: Modifier genes and sickle cell anemia. Curr Opin Hematol. 2006, 13: 131-136. 10.1097\/01.moh.0000219656.50291.73.","journal-title":"Curr Opin Hematol"},{"key":"1140_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1365-2141.2005.05411.x","volume":"129","author":"MH Steinberg","year":"2005","unstructured":"Steinberg MH: Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005, 129: 465-481. 10.1111\/j.1365-2141.2005.05411.x.","journal-title":"Br J Haematol"},{"key":"1140_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1586\/ehm.10.44","volume":"3","author":"KY Fertrin","year":"2010","unstructured":"Fertrin KY, Costa FF: Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment. Expert Rev Hematol. 2010, 3: 443-458. 10.1586\/ehm.10.44.","journal-title":"Expert Rev Hematol"},{"key":"1140_CR8","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJM199904013401307","volume":"340","author":"MH Steinberg","year":"1999","unstructured":"Steinberg MH: Management of sickle cell disease. N Engl J Med. 1999, 340: 1021-1030. 10.1056\/NEJM199904013401307.","journal-title":"N Engl J Med"},{"key":"1140_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03630260802625709","volume":"33","author":"N Conran","year":"2009","unstructured":"Conran N, Franco-Penteado CF, Costa FF: Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin. 2009, 33: 1-16. 10.1080\/03630260802625709.","journal-title":"Hemoglobin"},{"key":"1140_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2174\/156652408786241384","volume":"8","author":"E Fibach","year":"2008","unstructured":"Fibach E, Rachmilewitz E: The role of oxidative stress in hemolytic anemia. Curr Mol Med. 2008, 8: 609-619. 10.2174\/156652408786241384.","journal-title":"Curr Mol Med"},{"key":"1140_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0950-3536(11)80023-5","volume":"5","author":"RL Nagel","year":"1992","unstructured":"Nagel RL, Fleming AF: Genetic epidemiology of the beta s gene. Baillieres Clin Haematol. 1992, 5: 331-365. 10.1016\/S0950-3536(11)80023-5.","journal-title":"Baillieres Clin Haematol"},{"key":"1140_CR12","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1073\/pnas.81.6.1771","volume":"81","author":"J Pagnier","year":"1984","unstructured":"Pagnier J, Mears JG, Dunda-Belkhodja O, Schaefer-Rego KE, Beldjord C, Nagel RL, et al: Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci U S A. 1984, 81: 1771-1773. 10.1073\/pnas.81.6.1771.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1140_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00043426-199023000-00022","volume":"12","author":"DR Powars","year":"1990","unstructured":"Powars DR, Chan L, Schroeder WA: Beta S-gene-cluster haplotypes in sickle cell anemia: clinical implications. Am J Pediatr Hematol Oncol. 1990, 12: 367-374. 10.1097\/00043426-199023000-00022.","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"1140_CR14","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1056\/NEJM198504043121403","volume":"312","author":"RL Nagel","year":"1985","unstructured":"Nagel RL, Fabry ME, Pagnier J, Zohoun I, Wajcman H, Baudin V, et al: Hematologically and genetically distinct forms of sickle cell anemia in Africa: the Senegal type and the Benin type. N Engl J Med. 1985, 312: 880-884. 10.1056\/NEJM198504043121403.","journal-title":"N Engl J Med"},{"key":"1140_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2141.1991.tb08013.x","volume":"79","author":"MA Padmos","year":"1991","unstructured":"Padmos MA, Roberts GT, Sackey K, Kulozik A, Bail S, Morris JS, et al: Two different forms of homozygous sickle cell disease occur in Saudi Arabia. Br J Haematol. 1991, 79: 93-98. 10.1111\/j.1365-2141.1991.tb08013.x.","journal-title":"Br J Haematol"},{"key":"1140_CR16","first-page":"7","volume":"91","author":"ZY Aliyu","year":"2006","unstructured":"Aliyu ZY, Tumblin AR, Kato GJ: Current therapy of sickle cell disease. Haematologica. 2006, 91: 7-10.","journal-title":"Haematologica"},{"key":"1140_CR17","first-page":"62","volume-title":"Hematology Am Soc Hematol Educ Program","author":"RE Ware","year":"2009","unstructured":"Ware RE, Aygun B: Advances in the use of hydroxyurea. Hematology Am Soc Hematol Educ Program. 2009, 62-69."},{"key":"1140_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1182\/blood.V99.1.10","volume":"99","author":"RE Ware","year":"2002","unstructured":"Ware RE, Eggleston B, Redding-Lallinger R, Wang WC, Smith-Whitley K, Daeschner C, et al: Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood. 2002, 99: 10-14. 10.1182\/blood.V99.1.10.","journal-title":"Blood"},{"key":"1140_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/1096-8652(200011)65:3<227::AID-AJH9>3.0.CO;2-V","volume":"65","author":"BS Baliga","year":"2000","unstructured":"Baliga BS, Pace BS, Chen HH, Shah AK, Yang YM: Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors. Am J Hematol. 2000, 65: 227-233. 10.1002\/1096-8652(200011)65:3<227::AID-AJH9>3.0.CO;2-V.","journal-title":"Am J Hematol"},{"key":"1140_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJM198404053101401","volume":"310","author":"NL Letvin","year":"1984","unstructured":"Letvin NL, Linch DC, Beardsley GP, McIntyre KW, Nathan DG: Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med. 1984, 310: 869-873. 10.1056\/NEJM198404053101401.","journal-title":"N Engl J Med"},{"key":"1140_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1126\/science.6200940","volume":"224","author":"T Papayannopoulou","year":"1984","unstructured":"Papayannopoulou T, De Torrealba RA, Veith R, Knitter G, Stamatoyannopoulos G: Arabinosylcytosine induces fetal hemoglobin in baboons by perturbing erythroid cell differentiation kinetics. Science. 1984, 224: 617-619. 10.1126\/science.6200940.","journal-title":"Science"},{"key":"1140_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1172\/JCI200316672","volume":"111","author":"VP Cokic","year":"2003","unstructured":"Cokic VP, Smith RD, Beleslin-Cokic BB, Njoroge JM, Miller JL, Gladwin MT, et al: Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J Clin Invest. 2003, 111: 231-239.","journal-title":"J Clin Invest"},{"key":"1140_CR23","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3181\/0811-RM-339","volume":"234","author":"TF Lou","year":"2009","unstructured":"Lou TF, Singh M, Mackie A, Li W, Pace BS: Hydroxyurea generates nitric oxide in human erythroid cells: mechanisms for gamma-globin gene activation. Exp Biol Med (Maywood). 2009, 234: 1374-1382. 10.3181\/0811-RM-339.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1140_CR24","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1182\/blood-2007-05-088732","volume":"111","author":"VP Cokic","year":"2008","unstructured":"Cokic VP, Andric SA, Stojilkovic SS, Noguchi CT, Schechter AN: Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells. Blood. 2008, 111: 1117-1123.","journal-title":"Blood"},{"key":"1140_CR25","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.exphem.2006.03.018","volume":"34","author":"JR Keefer","year":"2006","unstructured":"Keefer JR, Schneidereith TA, Mays A, Purvis SH, Dover GJ, Smith KD: Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells. Exp Hematol. 2006, 34: 1151-1161.","journal-title":"Exp Hematol"},{"key":"1140_CR26","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1182\/blood-2011-07-368746","volume":"118","author":"AL Walker","year":"2011","unstructured":"Walker AL, Steward S, Howard TA, Mortier N, Smeltzer M, Wang YD, et al: Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia. Blood. 2011, 118: 5664-5670. 10.1182\/blood-2011-07-368746.","journal-title":"Blood"},{"key":"1140_CR27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/archpedi.1993.02160350071011","volume":"147","author":"D Powars","year":"1993","unstructured":"Powars D, Hiti A: Sickle cell anemia: beta s gene cluster haplotypes as genetic markers for severe disease expression. Am J Dis Child. 1993, 147: 1197-1202.","journal-title":"Am J Dis Child"},{"key":"1140_CR28","first-page":"202","volume":"28","author":"DR Powars","year":"1991","unstructured":"Powars DR: Sickle cell anemia: beta s-gene-cluster haplotypes as prognostic indicators of vital organ failure. Semin Hematol. 1991, 28: 202-208.","journal-title":"Semin Hematol"},{"key":"1140_CR29","first-page":"46","volume-title":"ScientificWorldJournal","author":"MH Steinberg","year":"2009","unstructured":"Steinberg MH: Genetic etiologies for phenotypic diversity in sickle cell anemia. ScientificWorldJournal. 2009, 46-67."},{"key":"1140_CR30","first-page":"121","volume-title":"Metodologias laboratoriais para o diagn\u00f3stico de hemoglobinopatias e talassemias","author":"CR Bonini-Domingos","year":"2006","unstructured":"Bonini-Domingos CR: Metodologias laboratoriais para o diagn\u00f3stico de hemoglobinopatias e talassemias. 2006, Sao Paulo, Brazil: NH, 121-"},{"key":"1140_CR31","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.2999980","volume":"230","author":"RK Saiki","year":"1985","unstructured":"Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al: Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle-cell anemia. Science. 1985, 230: 1350-1354. 10.1126\/science.2999980.","journal-title":"Science"},{"key":"1140_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ajh.2830320113","volume":"32","author":"M Sutton","year":"1989","unstructured":"Sutton M, Bouhassira EE, Nagel RL: Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes. Am J Hematol. 1989, 32: 66-69. 10.1002\/ajh.2830320113.","journal-title":"Am J Hematol"},{"key":"1140_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","volume":"86","author":"M Uchiyama","year":"1978","unstructured":"Uchiyama M, Mihara M: Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978, 86: 271-278. 10.1016\/0003-2697(78)90342-1.","journal-title":"Anal Biochem"},{"key":"1140_CR34","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","volume":"26","author":"R Re","year":"1999","unstructured":"Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C: Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999, 26: 1231-1237. 10.1016\/S0891-5849(98)00315-3.","journal-title":"Free Radic Biol Med"},{"key":"1140_CR35","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1016\/S0021-9258(20)81842-0","volume":"251","author":"JH Keen","year":"1976","unstructured":"Keen JH, Habig WH, Jakoby WB: Mechanism for several activities of glutathione S-transferases. J Biol Chem. 1976, 251: 6183-6188.","journal-title":"J Biol Chem"},{"key":"1140_CR36","first-page":"919","volume":"83","author":"E Beutler","year":"1975","unstructured":"Beutler E: Red cell metabolism: a manual of biochemical methods. Ann Intern Med. 1975, 83: 919-","journal-title":"Ann Intern Med"},{"key":"1140_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0378-4347(94)00111-1","volume":"656","author":"A Rodriguez-Ariza","year":"1994","unstructured":"Rodriguez-Ariza A, Toribio F, Lopezbarea J: Rapid-determination of glutathione status in fish liver using high-performance liquid-chromatography and electrochemical detection. J Chromatogr B Biomed Appl. 1994, 656: 311-318. 10.1016\/0378-4347(94)00111-1.","journal-title":"J Chromatogr B Biomed Appl"},{"key":"1140_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1034\/j.1600-0609.2003.00016.x","volume":"70","author":"A Inati","year":"2003","unstructured":"Inati A, Taher A, Bou AW, Koussa S, Kaspar H, Shbaklo H, et al: Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon. Eur J Haematol. 2003, 70: 79-83. 10.1034\/j.1600-0609.2003.00016.x.","journal-title":"Eur J Haematol"},{"key":"1140_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000320271","volume":"124","author":"AR Belisario","year":"2010","unstructured":"Belisario AR, Martins ML, Brito AM, Rodrigues CV, Silva CM, Viana MB: Beta-globin gene cluster haplotypes in a cohort of 221 children with sickle cell anemia or Sbeta-thalassemia and their association with clinical and hematological features. Acta Haematol. 2010, 124: 162-170. 10.1159\/000320271.","journal-title":"Acta Haematol"},{"key":"1140_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/(SICI)1096-8652(199610)53:2<72::AID-AJH3>3.0.CO;2-0","volume":"53","author":"MS Figueiredo","year":"1996","unstructured":"Figueiredo MS, Kerbauy J, Goncalves MS, Arruda VR, Saad ST, Sonati MF, et al: Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil. Am J Hematol. 1996, 53: 72-76. 10.1002\/(SICI)1096-8652(199610)53:2<72::AID-AJH3>3.0.CO;2-0.","journal-title":"Am J Hematol"},{"key":"1140_CR41","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000154238","volume":"44","author":"MS Gon\u00e7alves","year":"1994","unstructured":"Gon\u00e7alves MS, Nechtman JF, Figueiredo MS, Kerbauy J, Arruda VR, Sonati MF, et al: Sickle cell disease in a Brazilian population from Sao Paulo: a study of the beta S haplotypes. Hum Hered. 1994, 44: 322-327. 10.1159\/000154238.","journal-title":"Hum Hered"},{"key":"1140_CR42","first-page":"7","volume":"8","author":"MS Figueiredo","year":"1994","unstructured":"Figueiredo MS, Silva MC, Guerreiro JF, Souza GP, Pires AC, Zago MA: The heterogeneity of the beta s cluster haplotypes in Brazil. Gene Geogr. 1994, 8: 7-12.","journal-title":"Gene Geogr"},{"key":"1140_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ajpa.1330880304","volume":"88","author":"MA Zago","year":"1992","unstructured":"Zago MA, Figueiredo MS, Ogo SH: Bantu beta s cluster haplotype predominates among Brazilian blacks. Am J Phys Anthropol. 1992, 88: 295-298. 10.1002\/ajpa.1330880304.","journal-title":"Am J Phys Anthropol"},{"issue":"4","key":"1140_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00277-011-1340-y","volume":"91","author":"E Belini-Junior","year":"2012","unstructured":"Belini-Junior E, Da Silva DG, De Souza TL, De Almeida EA, Cancado RD, Chiattone C: Oxidative stress and antioxidant capacity in sickle cell anaemia patients receiving different treatments and medications for different periods of time. Ann Hematol. 2012, 91 (4): 479-489. 10.1007\/s00277-011-1340-y.","journal-title":"Ann Hematol"},{"key":"1140_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ajh.2830290117","volume":"29","author":"R Srinivas","year":"1988","unstructured":"Srinivas R, Dunda O, Krishnamoorthy R, Fabry ME, Georges A, Labie D, et al: Atypical haplotypes linked to the beta S gene in Africa are likely to be the product of recombination. Am J Hematol. 1988, 29: 60-62. 10.1002\/ajh.2830290117.","journal-title":"Am J Hematol"},{"key":"1140_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bcmd.2011.03.004","volume":"47","author":"DG Silva","year":"2011","unstructured":"Silva DG, Belini-Junior E, Torres LS, Ricci-Junior , Lobo CC, Bonini-Domingos CR, et al: Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia. Blood Cells Mol Dis. 2011, 47: 23-28. 10.1016\/j.bcmd.2011.03.004.","journal-title":"Blood Cells Mol Dis"},{"key":"1140_CR47","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1073\/pnas.90.11.5039","volume":"90","author":"WN Poillon","year":"1993","unstructured":"Poillon WN, Kim BC, Rodgers GP, Noguchi CT, Schechter AN: Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations. Proc Natl Acad Sci USA. 1993, 90: 5039-5043. 10.1073\/pnas.90.11.5039.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1140_CR48","doi-asserted-by":"publisher","first-page":"R394","DOI":"10.1152\/ajpregu.00611.2009","volume":"298","author":"T Dasgupta","year":"2010","unstructured":"Dasgupta T, Fabry ME, Kaul DK: Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice. Am J Physiol Regul Integr Comp Physiol. 2010, 298: R394-R402. 10.1152\/ajpregu.00611.2009.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1140_CR49","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1600-0609.2010.01528.x","volume":"85","author":"I Rusanova","year":"2010","unstructured":"Rusanova I, Escames G, Cossio G, De Borace RG, Moreno B, Chahboune M, et al: Oxidative stress status, clinical outcome, and beta-globin gene cluster haplotypes in pediatric patients with sickle cell disease. Eur J Haematol. 2010, 85: 529-537. 10.1111\/j.1600-0609.2010.01528.x.","journal-title":"Eur J Haematol"},{"key":"1140_CR50","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature01626","volume":"422","author":"FS Collins","year":"2003","unstructured":"Collins FS, Green ED, Guttmacher AE, Guyer MS: A vision for the future of genomics research. Nature. 2003, 422: 835-847. 10.1038\/nature01626.","journal-title":"Nature"},{"key":"1140_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ajh.20293","volume":"78","author":"P Vicari","year":"2005","unstructured":"Vicari P, De Barretto MA, Figueiredo MS: Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia. Am J Hematol. 2005, 78: 243-244. 10.1002\/ajh.20293.","journal-title":"Am J Hematol"},{"key":"1140_CR52","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V79.10.2555.2555","volume":"79","author":"S Charache","year":"1992","unstructured":"Charache S, Dover GJ, Moore RD, Eckert S, Ballas SK, Koshy M, et al: Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood. 1992, 79: 2555-2565.","journal-title":"Blood"},{"key":"1140_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ajh.2830450120","volume":"45","author":"FF Costa","year":"1994","unstructured":"Costa FF, Arruda VR, Goncalves MG, Miranda SR, Carvalho MH, Sonati MF, et al: Beta S-gene-cluster haplotypes in sickle cell anemia patients from two regions of Brazil. Am J Hematol. 1994, 45: 96-97.","journal-title":"Am J Hematol"},{"key":"1140_CR54","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood.V89.3.1078","volume":"89","author":"MH Steinberg","year":"1997","unstructured":"Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S, Dover GJ: Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea: multicenter study of hydroxyurea. Blood. 1997, 89: 1078-1088.","journal-title":"Blood"},{"key":"1140_CR55","first-page":"364","volume":"62","author":"JB Schnog","year":"2004","unstructured":"Schnog JB, Duits AJ, Muskiet FA, Ten CH, Rojer RA, Brandjes DP: Sickle cell disease: a general overview. Neth J Med. 2004, 62: 364-374.","journal-title":"Neth J Med"},{"key":"1140_CR56","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood.V94.6.1864","volume":"94","author":"BL Ebert","year":"1999","unstructured":"Ebert BL, Bunn HF: Regulation of the erythropoietin gene. Blood. 1999, 94: 1864-1877.","journal-title":"Blood"},{"key":"1140_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<15::AID-AJH4>3.0.CO;2-2","volume":"59","author":"K Lee","year":"1998","unstructured":"Lee K, Prehu C, Merault G, Keclard L, Roudot-Thoraval F, Bachir D, et al: Genetic and hematological studies in a group of 114 adult patients with SC sickle cell disease. Am J Hematol. 1998, 59: 15-21. 10.1002\/(SICI)1096-8652(199809)59:1<15::AID-AJH4>3.0.CO;2-2.","journal-title":"Am J Hematol"},{"key":"1140_CR58","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/blood.V77.6.1371.1371","volume":"77","author":"RL Nagel","year":"1991","unstructured":"Nagel RL, Erlingsson S, Fabry ME, Croizat H, Susuka SM, Lachman H, et al: The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients. Blood. 1991, 77: 1371-1375.","journal-title":"Blood"},{"key":"1140_CR59","first-page":"745","volume":"5","author":"N Wiles","year":"2009","unstructured":"Wiles N, Howard J: Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease. Ther Clin Risk Manag. 2009, 5: 745-755.","journal-title":"Ther Clin Risk Manag"},{"issue":"114","key":"1140_CR60","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1182\/blood-2009-04-218040","volume":"19","author":"VR Gordeuk","year":"2009","unstructured":"Gordeuk VR, Campbell A, Rana S, Nouraie M, Niu X, Minniti CP, et al: Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease. Blood. 2009, 19 (114): 4639-4644.","journal-title":"Blood"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-14-108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-14-108\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-14-108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-14-108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T17:59:22Z","timestamp":1646762362000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-14-108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,9]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1140"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-14-108","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,9]]},"assertion":[{"value":"17 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"108"}}